What is Protagonist Therapeutics's free cash flow margin?

Protagonist Therapeutics (PTGX) reported free cash flow margin of -12,264.3% in Q1 2023.

How has Protagonist Therapeutics's free cash flow margin changed year-over-year?

Protagonist Therapeutics's free cash flow margin decreased by 4773.1% year-over-year, from -251.7% to -12,264.3%.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Protagonist Therapeutics PTGX Free cash flow margin

Discontinued — last reported Q1 '23

Free cash flow margin at other companies

Bristol-Myers SquibbBMY

24.6%-2.9pp

Eli LillyLLY

16.4%+8.7pp

AmgenAMGN

23.1%-8.9pp

IncyteINCY

28.2%+19.7pp

AbbVieABBV

31.8%+5.0pp

Regeneron PharmaceuticalsREGN

27.6%+5.5pp

Other financials

Income statement

See full

Revenue$56.4M+99.0%

Operating income-$3.6M+81.1%

Net income$3.8M+132%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$193.7M+38.7%

Total debt$9.8M-13.9%

Total equity$655.5M-4.9%

Total assets$697.5M-6.0%

Cash flow

See full

Operating cash flow-$48.9M-139%

CapEx$215.0K-60.6%

Free cash flow-$49.2M-139%

Valuation

See full

Market cap$7.26B+127%

Enterprise value$7.07B+130%

P/S98×+82.6×

Profitability

See full

Operating margin-192.4%-205pp

Net margin-154.9%-182pp

Returns & leverage

See full

Return on equity-17.1%-26.1pp

Debt / equity0×0.0×

Current ratio17.8×+0.5×

Where this comes from

Calculated from Protagonist Therapeutics’s reported figures.

free cash flow/total revenue=-12,264.3%

Based on trailing twelve months.

The official record: Protagonist Therapeutics’s 10-Q, filed May 7, 2024, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Protagonist Therapeutics's free cash flow margin?: Protagonist Therapeutics (PTGX) reported free cash flow margin of -12,264.3% in Q1 2023.
How has Protagonist Therapeutics's free cash flow margin changed year-over-year?: Protagonist Therapeutics's free cash flow margin decreased by 4773.1% year-over-year, from -251.7% to -12,264.3%.
What does free cash flow margin mean?: Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.